Reports
Sale
Global Human Growth Hormone Market Size, Share: By Application: Growth Hormone Deficiency, Turner Syndrome, Idiopathic Short Stature, Prader-Willi Syndrome, Other Applications; By Distribution Channel: Hospitals and Retail Pharmacies, Online Pharmacies, Other Distribution Channels; Regional Analysis; Supplier Landscape; 2024-2032
Global Human Growth Hormone Market Outlook
The global human growth hormone market size was valued at USD 5.64 billion in 2023, driven by the rising deficiency of growth hormones and associated conditions across the globe. The market is anticipated to grow at a CAGR of 8.5% during the forecast period of 2024-2032 to achieve a value of USD 11.75 billion by 2032.
Human Growth Hormone: Introduction
Human growth hormone (HGH) is a hormone which is secreted naturally by pituitary gland in the brain. It is also called as somatotrophin. It is responsible for regulating and stimulating growth in kids, and help in regulating multiple psychological processes in adults as well. Human growth hormone is responsible for the overall health of an individual be that a kid or an adult. It takes care of the muscle growth, bone growth, performance of metabolism, along with repairing of cells and tissues in body. Synthetic versions of human growth hormones, also known as recombinant human growth hormone (rhGH), are used for medical purposes. These synthetic versions of human growth hormone are widely prescribed to treat conditions such as growth hormone deficiency, Turner syndrome, Prader-Willi syndrome, and chronic kidney disease.
Additionally, it is sometimes used off-label for conditions like muscle wasting associated with HIV/AIDS or for anti-aging purposes. It is also used illicitly in the sports community for performance enhancement. However, the use of human growth hormone is prohibited for such purposes in sports business it is considered as doping by the authorities.
Global Human Growth Hormone Market Analysis
The reason for a child's rapid growth in their childhood and adolescence is the high production of this hormone during that time. However, with time the secretion of this hormone starts to reduce, resulting in decline of all the health factors that are associated with it such as cell and tissue repairing, metabolism, bone density and muscle mass. The decline in the secretion is considered to be associated with the aging process and factors associated with aging.
There are several trends leading the human growth hormone market growth, including the increased demand of human growth hormone therapy. The market is recording evident growth as the demand for human growth hormone therapies has been booming due the rising desire to enhance the performance and slow down aging, and other issue related to age.
Additionally, the ongoing research on development of alternate delivery methods in order to increase the patient convenience and compliance is also anticipated to aid the human growth hormone market development.
Some other key trends in the market include the proper surveillance for the appropriate uses and regulation of human growth hormones in the market, increasing emphasis on the personalized medicine and treatments, increasing focus on the potential of human growth hormone in fields other than deficiency recovery and growth factors such as sports medicine, anti-ageing and some other.
Human Growth Hormone Market Segmentations
Market Breakup by Application
- Growth Hormone Deficiency
- Turner Syndrome
- Idiopathic Short Stature
- Prader-Willi Syndrome
- Other Applications
Market Breakup by Distribution Channel
- Hospitals and Retail Pharmacies
- Online Pharmacies
- Other Distribution Channels
Market Breakup by Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Human Growth Hormone Market Overview
The market for human growth hormone has been witnessing evident growth in the past and is expected to see the growth in coming years as well. There factors driving the market growth are rising deficiency of growth hormones and associated conditions. This increase in deficiency is also aiding the global human growth hormone market expansion. Due to the technological advancement in the field, the availability has increased and has become more affordable. With the advanced development in recombinant DNA technology, the manufacturing of synthetic hormone has been introduced and put to practical use as well.
Additionally, the increasing awareness and knowledge on the merits of human growth hormone on physical performance, body composition and overall well-being are also likely to aid the market growth.
Human Growth Hormone Market: Competitor Landscape
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- AnkeBio Co. Ltd
- Eli Lilly and Company
- Ferring BV
- Novo Nordisk AS
- Ipsen SA
- Pfizer Inc.
- Genentech Inc. (Roche)
- Teva Pharmaceutical Industries Ltd.
- Ferring BV
- Anhui Anke Biotechnology (Group) Co.
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Application |
|
| Breakup by Distribution Channel |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Human Growth Hormone Market Overview
3.1 Global Human Growth Hormone Market Historical Value (2017-2023)
3.2 Global Human Growth Hormone Market Forecast Value (2024-2032)
4 Global Human Growth Hormone Market Landscape
4.1 Human Growth Hormone Devices: Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Human Growth Hormone Devices: Product Landscape
4.2.1 Analysis by Age Group
4.2.2 Analysis by Applications
5 Global Human Growth Hormone Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Human Growth Hormone Market Segmentation
6.1 Global Human Growth Hormone Market by Application
6.1.1 Market Overview
6.1.2 Growth Hormone Deficiency
6.1.3 Turner Syndrome
6.1.4 Idiopathic Short Stature
6.1.5 Prader-Willi Syndrome
6.1.6 Other Applications
6.2 Global Human Growth Hormone Market by Distribution Channel
6.2.1 Market Overview
6.2.2 Hospitals and Retail Pharmacies
6.2.3 Online Pharmacies
6.2.4 Other Distribution Channels
6.3 Global Human Growth Hormone Market by Region
6.3.1 Market Overview
6.3.2 North America
6.3.3 Europe
6.3.4 Asia Pacific
6.3.5 Latin America
6.3.6 Middle East and Africa
7 North America Growth Hormone Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Human Growth Hormone Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Human Growth Hormone Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Human Growth Hormone Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Human Growth Hormone Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Regulatory Framework
12.1 Regulatory Overview
12.1.1 US FDA
12.1.2 EU EMA
12.1.3 INDIA CDSCO
12.1.4 JAPAN PMDA
12.1.5 Others
13 Patent Analysis
13.1 Analysis by Type of Patent
13.2 Analysis by Publication year
13.3 Analysis by Issuing Authority
13.4 Analysis by Patent Age
13.5 Analysis by CPC Analysis
13.6 Analysis by Patent Valuation
13.7 Analysis by Key Players
14 Grants Analysis
14.1 Analysis by year
14.2 Analysis by Amount Awarded
14.3 Analysis by Issuing Authority
14.4 Analysis by Grant Application
14.5 Analysis by Funding Institute
14.6 Analysis by NIH Departments
14.7 Analysis by Recipient Organization
15 Clinical Trials Analysis
15.1 Analysis by Trial Registration Year
15.2 Analysis by Trial Status
15.3 Analysis by Trial Phase
15.4 Analysis by Therapeutic Area
15.5 Analysis by Geography
16 Funding and Investment Analysis
16.1 Analysis by Funding Instances
16.2 Analysis by Type of Funding
16.3 Analysis by Funding Amount
16.4 Analysis by Leading Players
16.5 Analysis by Leading Investors
16.6 Analysis by Geography
17 Partnership and Collaborations Analysis
17.1 Analysis by Partnership Instances
17.2 Analysis by Type of Partnership
17.3 Analysis by Leading Players
17.4 Analysis by Geography
18 Supplier Landscape
18.1 AnkeBio Co. Ltd
18.1.1 Financial Analysis
18.1.2 Product Portfolio
18.1.3 Demographic Reach and Achievements
18.1.4 Mergers and Acquisitions
18.1.5 Certifications
18.2 Eli Lilly and Company
18.2.1 Financial Analysis
18.2.2 Product Portfolio
18.2.3 Demographic Reach and Achievements
18.2.4 Mergers and Acquisitions
18.2.5 Certifications
18.3 Ferring BV
18.3.1 Financial Analysis
18.3.2 Product Portfolio
18.3.3 Demographic Reach and Achievements
18.3.4 Mergers and Acquisitions
18.3.5 Certifications
18.4 Novo Nordisk AS
18.4.1 Financial Analysis
18.4.2 Product Portfolio
18.4.3 Demographic Reach and Achievements
18.4.4 Mergers and Acquisitions
18.4.5 Certifications
18.5 Ipsen SA
18.5.1 Financial Analysis
18.5.2 Product Portfolio
18.5.3 Demographic Reach and Achievements
18.5.4 Mergers and Acquisitions
18.5.5 Certifications
18.6 Pfizer Inc.
18.6.1 Financial Analysis
18.6.2 Product Portfolio
18.6.3 Demographic Reach and Achievements
18.6.4 Mergers and Acquisitions
18.6.5 Certifications
18.7 Genentech Inc. (Roche)
18.7.1 Financial Analysis
18.7.2 Product Portfolio
18.7.3 Demographic Reach and Achievements
18.7.4 Mergers and Acquisitions
18.7.5 Certifications
18.8 Teva Pharmaceutical Industries Ltd.
18.8.1 Financial Analysis
18.8.2 Product Portfolio
18.8.3 Demographic Reach and Achievements
18.8.4 Mergers and Acquisitions
18.8.5 Certifications
18.9 Ferring BV
18.9.1 Financial Analysis
18.9.2 Product Portfolio
18.9.3 Demographic Reach and Achievements
18.9.4 Mergers and Acquisitions
18.9.5 Certifications
18.10 Anhui Anke Biotechnology (Group) Co.
18.10.1 Financial Analysis
18.10.2 Product Portfolio
18.10.3 Demographic Reach and Achievements
18.10.4 Mergers and Acquisitions
18.10.5 Certifications
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
Key Questions Answered in the Report
The market attained a value of about USD 5.64 billion in 2023, driven by the prevalence of rising deficiency of growth hormones.
The market size is anticipated to grow at a CAGR of 8.5% during the forecast period of 2024-2032 to reach a value of USD 11.75 billion by 2032.
The rising deficiency of growth hormones and associated conditions are major drivers for the human growth hormone market.
The increased demand of human growth hormone therapy in the market is among the major key trends in the market.
The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East and Africa, North America has been leading the global market.
They find wide application in Growth Hormone Deficiency, Turner Syndrome, Idiopathic Short Stature, and Prader-Willi Syndrome, among other applications.
The different distribution channel in the market includes hospitals and retail pharmacies, online pharmacies, among other distribution channels.
Key players involved in the market are AnkeBio Co. Ltd, Eli Lilly and Company, Ferring BV, Novo Nordisk AS, Ipsen SA, Pfizer Inc., Genentech Inc. (Roche), Teva Pharmaceutical Industries Ltd., Anhui Anke Biotechnology (Group) Co., and Ferring BV.
Purchase Options 10% off
Call us
Purchase Full Report
Mini Report
$ 2969
$2699
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 5499
$4999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 6599
$5999
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 7699
$6999
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER